Korean Coronary Bifurcation Stenting (COBIS) Registry III (COBIS III)

Samsung Medical Center

Status: Completed

Conditions: Coronary Bifurcation Lesion

Study type: Observational

Funder types: Other

Identifiers

NCT03068494

2016-12-136

Details and patient eligibility

About

The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.

Enrollment: 2,648 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age >=19 years
• Any type of de novo bifurcation lesion in major epicardial artery: unprotected left main coronary bifurcation lesion, LAD - diagonal, LCX-OM, distal RCA bifurcation. (Excluding RCA-RV branch bifurcation, branch bifurcation)
• Side branch or LCX reference diameter >= 2.3 mm and at least stentable with 2.5 mm stent
• Treated with drug-eluting stent during the period of 2010. 1 ~ 2014. 12

Exclusion criteria

• Protected left main disease previous CABG for LAD or LCX territory
• Cardiogenic Shock
• History of CPR in the same hospitalization
• Patients with severe left ventricular systolic dysfunction (ejection fraction < 30%)

Trial design

2,648 participants in 1 patient group

Coronary Bifurcation Lesion